D
Deborah J. Cook
Researcher at McMaster University
Publications - 942
Citations - 165225
Deborah J. Cook is an academic researcher from McMaster University. The author has contributed to research in topics: Intensive care & Randomized controlled trial. The author has an hindex of 173, co-authored 907 publications receiving 148928 citations. Previous affiliations of Deborah J. Cook include McMaster University Medical Centre & Queen's University.
Papers
More filters
Journal ArticleDOI
Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis
Vikram R. Comondore,Philip J. Devereaux,Qi Zhou,Samuel B Stone,Jason W. Busse,Nikila C Ravindran,Karen E. A. Burns,Ted Haines,Bernadette Stringer,Deborah J. Cook,Stephen D. Walter,Terrence Sullivan,Otavio Berwanger,Mohit Bhandari,Sarfaraz Banglawala,John N. Lavis,Brad Petrisor,Holger J. Schünemann,Katie Walsh,Neera Bhatnagar,Gordon H. Guyatt +20 more
TL;DR: This systematic review and meta-analysis of the evidence suggests that, on average, not-for-profits nursing homes deliver higher quality care than do for-profit nursing homes.
Journal ArticleDOI
Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis
TL;DR: Oral decontamination of mechanically ventilated adults using antiseptics is associated with a lower risk of ventilator associated pneumonia, and neither antiseptic nor antibiotic oral decontamination reduced mortality or duration of mechanical ventilation or stay in the intensive care unit.
Journal ArticleDOI
Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units
Simon Finfer,Bette Liu,Bette Liu,Colman Taylor,Rinaldo Bellomo,Laurent Billot,Deborah J. Cook,Bin Du,Colin McArthur,John Myburgh +9 more
TL;DR: Although colloid solutions are more expensive and may possibly be harmful in some patients, they were administered to more patients and during more resuscitation episodes than crystalloids were and choice of fluid varies markedly between countries.
Journal ArticleDOI
Dalteparin versus unfractionated heparin in critically ill patients.
Deborah J. Cook,Maureen O. Meade,Gordon H. Guyatt,Stephen D. Walter,Diane Heels-Ansdell,Theodore E. Warkentin,Nicole Zytaruk,Mark Crowther,William Geerts,D. Jamie Cooper,Shirley Vallance,Ismael Qushmaq,Marcelo G. Rocha,Otavio Berwanger,Nicholas E. Vlahakis +14 more
TL;DR: In this article, the authors evaluated the effect of low-molecular-weight heparin on venous thromboembolism, bleeding, and other outcomes in critically ill patients.
Journal ArticleDOI
Deep Vein Thrombosis and Its Prevention in Critically Ill Adults
TL;DR: Critically ill patients commonly develop DVT, with rates that vary from 22% to almost 80%, depending on patient characteristics, so more potent prophylactic regimens other than unfractionated or low-molecular-weight heparins alone may be needed with higher-risk groups.